Canadian Atrial Fibrillation Anticoagulation Study "CAFA"

Completed

Phase N/A Results

Summary of Purpose

To assess the potential of warfarin to reduce systemic thromboembolism and its inherent risk of hemorrhage.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 26 July 2001.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Trial Design

Randomized, double-blind, placebo-controlled trial of 378 patients.

Contacts

Not available